Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Acrivon Therapeutics, Inc. | 2,245,317 | reported | 21 May 2026 | tx 33+3,748,371−700,727 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 21 May 2026 | TAX_WITHHOLDING | Acrivon Therapeutics, Inc. | 13,729 | 1.79 USD | |
| 18 May 2026 | GRANT_AWARD | Acrivon Therapeutics, Inc. | 180,095 | 0.00 USD | |
| 18 May 2026 | GRANT_AWARD | Acrivon Therapeutics, Inc. | 72,706 | 0.00 USD | |
| 14 May 2026 | TAX_WITHHOLDING | Acrivon Therapeutics, Inc. | 1,253 | 1.92 USD | |
| 14 May 2026 | TAX_WITHHOLDING | Acrivon Therapeutics, Inc. | 490 | 1.92 USD | |
| 01 Mar 2026 | GRANT_AWARD | Acrivon Therapeutics, Inc. | 185,495 | 0.00 USD | deriv |
| 01 Mar 2026 | GRANT_AWARD | Acrivon Therapeutics, Inc. | 417,210 | 0.00 USD | deriv |
| 21 Feb 2026 | TAX_WITHHOLDING | Acrivon Therapeutics, Inc. | 14,265 | 1.53 USD | |
| 14 Feb 2026 | TAX_WITHHOLDING | Acrivon Therapeutics, Inc. | 579 | 1.63 USD | |
| 14 Feb 2026 | TAX_WITHHOLDING | Acrivon Therapeutics, Inc. | 1,302 | 1.63 USD | |
| 14 Jan 2026 | PURCHASE | Acrivon Therapeutics, Inc. | 49,000 | 1.68 USD | |
| 21 May 2025 | TAX_WITHHOLDING | Acrivon Therapeutics, Inc. | 19,904 | 1.15 USD | |
| 14 May 2025 | TAX_WITHHOLDING | Acrivon Therapeutics, Inc. | 491 | 1.14 USD | |
| 14 May 2025 | TAX_WITHHOLDING | Acrivon Therapeutics, Inc. | 59,766 | 1.14 USD | |
| 01 Mar 2025 | GRANT_AWARD | Acrivon Therapeutics, Inc. | 140,540 | 0.00 USD | deriv |
| 01 Mar 2025 | GRANT_AWARD | Acrivon Therapeutics, Inc. | 390,390 | 0.00 USD | deriv |
| 21 Feb 2025 | TAX_WITHHOLDING | Acrivon Therapeutics, Inc. | 19,904 | 5.54 USD | |
| 14 Nov 2024 | TAX_WITHHOLDING | Acrivon Therapeutics, Inc. | 59,766 | 7.92 USD | |
| 14 Nov 2024 | TAX_WITHHOLDING | Acrivon Therapeutics, Inc. | 490 | 7.92 USD | |
| 21 Aug 2024 | TAX_WITHHOLDING | Acrivon Therapeutics, Inc. | 79,616 | 9.19 USD | |
| 14 Aug 2024 | TAX_WITHHOLDING | Acrivon Therapeutics, Inc. | 59,765 | 7.02 USD | |
| 14 May 2024 | TAX_WITHHOLDING | Acrivon Therapeutics, Inc. | 54,918 | 8.36 USD | |
| 14 Feb 2024 | TAX_WITHHOLDING | Acrivon Therapeutics, Inc. | 41,861 | 3.40 USD | |
| 14 Nov 2023 | TAX_WITHHOLDING | Acrivon Therapeutics, Inc. | 239,023 | 5.08 USD | |
| 21 Aug 2023 | GRANT_AWARD | Acrivon Therapeutics, Inc. | 493,994 | 0.00 USD |